Pre‐emptive antifungal therapy vs empirical antifungal therapy
All‐cause mortality · people with cancer who have febrile neutropenia
Pre‐emptive antifungal therapy showed no clear difference in all‐cause mortality compared with empirical antifungal therapy (low certainty).
1 finding from 1 review
- Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer 2022 · Cochrane Headline outcomes onlyRR 0.97 [0.72, 1.3]6 studies · 1459 participantsLow